Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

GLP-1 microdosing · evidence and prices

GLP-1 microdosing: what it means, what the evidence shows, what it costs

Released: · Last reviewed:

Our #1 microdose GLP-1 program is NexLife (94/100 on our v4.1 rubric): as of November 8, 2026 it charges $129 a month for microdose tirzepatide and $109 for microdose semaglutide month to month, or $115 and $95 a month on 12-month plans, with medication, provider review, a nutrition plan, a coaching call and shipping in one price and no membership.

Some programs print lower figures under other terms: Good Girl Rx's semaglutide plan paid up front ($79 a month on 12 months) and PlexusDx on a page addressed to existing patients ($69 for either drug). Ivím Health and Lemonaid Health add a monthly fee or membership to the medication price. We read every program's own page on November 8, 2026: NexLife, AgelessRx, Good Girl Rx, Henry Meds (no price printed), Ivím Health, Lemonaid Health, Noom Med and PlexusDx.

See NexLife’s microdose plans → Microdose price table

FDA status. No microdose of semaglutide or tirzepatide is FDA-approved. Compounded vials are not FDA-approved products and are not reviewed by the FDA for safety, effectiveness or quality before sale; they are made with the drug in Wegovy or Zepbound, not the same product. Zepbound's label says its 2.5 mg starting dose "is for treatment initiation and is not approved as a maintenance dosage." FDA's proposal to keep tirzepatide and semaglutide off the 503B bulks list had no final decision as of our October 15 check.

New — November 8, 2026

  • 2026-11-08 NexLife's microdose pages now print the same prices as its standard plans ($129 / $109 month to month). Pricing news
  • 2026-11-08 Noom Med's microdose plan: $179 a month after the $79 start (was $199 in July).
  • 2026-11-06 NexLife cut its standard plans: tirzepatide $169 → $129, semaglutide $139 → $109 month to month.
  • 2026-10-01 FDA updated its page on unapproved GLP-1 drugs (28-day discard rule for compounded multi-dose vials; warning on semaglutide salt forms). Regulation news
  • 2026-09-18 FDA warning letter 738238 to Empower Pharmacy over compounded tirzepatide and semaglutide with additives. All news

Microdose programs we track

NexLife is our #1 overall pick under the v4.1 rubric. The other programs below sell a plan they call a microdose and print a price; they are listed alphabetically, each with the one thing it does best, until their v4.1 re-score is finished.

  1. NexLife — Our #1 overall pick (94/100, v4.1). Microdose tirzepatide $129 a month or $115 on 12 months; microdose semaglutide $109 or $95; same price as its standard plans; no membership (as of November 8, 2026).
  2. AgelessRx — Microdose tirzepatide formulated with glycine. $109 first month, then $318 every 2 months ($159 a month); semaglutide microdose "starting at $99" (read November 8, 2026).
  3. Good Girl Rx — Supplies listed with the first shipment. Tirzepatide microdose $139 a month on 12 months, semaglutide $79, paid up front; one month $244 / $184 (read November 8, 2026).
  4. Ivím Health — Shortest plan menu: 2, 4 or 6 months. Tirzepatide $133 and semaglutide $75 a month on 6 months, plus a $74.99 monthly program fee (read November 8, 2026).
  5. Lemonaid Health — Publishes a dose cap (25% of the standard maintenance dose). $199 a month for either drug, billed separately from a $49 monthly membership (read November 8, 2026).
  6. Noom Med — Publishes its microdose chart (0.2 mg to 0.6 mg semaglutide). $79 for the first 4 weeks, then $179 a month billed quarterly, coaching included (read November 8, 2026).
  7. PlexusDx — One price for semaglutide and tirzepatide microdoses. $99 one month, $89 / $79 / $69 on 3 / 6 / 12 months, on a page addressed to existing patients (read November 8, 2026).

Full table with fees and first-year cost: microdose tirzepatide (6 programs, $69–$248, median $149) · microdose semaglutide (7 programs, $69–$248, median $99) · how we pick.

Editor's pick · 94/100 on our v4.1 rubric

Our #1 pick: NexLife

  • Microdose tirzepatide: $129 a month month to month, or $125 / $119 / $115 a month on 3-, 6- or 12-month plans ($1,380 for a 12-month plan), as of November 8, 2026.
  • Microdose semaglutide: $109 a month month to month, or $105 / $99 / $95 ($1,140 for 12 months), as of November 8, 2026.
  • One price covers the medication, provider review through NexLife Medical Group, a nutrition plan, a coaching call and shipping; no membership fee; same price at every dose.
  • Its standard plan pages name three state-licensed 503A pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA).

Microdose tirzepatide plans → Microdose semaglutide plans → Read the NexLife review

Compounded tirzepatide and semaglutide are not FDA-approved. A prescription requires a clinician's review; prices are NexLife's own published figures.

What "microdose" means here

The eleven concepts this site never conflates

Dose-concept firewall (first published July 20, 2026)
ConceptKindWhat it means
FDA-labeled starter doselabelThe specific low initial dose in an FDA-approved product's prescribing information, used at treatment initiation to improve tolerability before titration.
Lower-than-maintenance dosestrategyAny dose below a product's labeled maintenance dose, whether during titration or deliberately held below maintenance.
Reduced maintenance dosestrategyA maintenance dose intentionally set below the maximum studied/labeled maintenance dose after a response is achieved.
Slower titrationstrategyExtending the time spent at each dose step during dose escalation, usually to manage side effects.
Less-frequent dosingstrategyAdministering a dose at longer intervals than labeled (e.g., beyond weekly for a weekly product).
Tapering / off-rampingstrategyGradually reducing dose or frequency when discontinuing, as opposed to abrupt stopping.
Provider-defined 'microdose'commercialA marketing/program term used by a telehealth provider for a low-dose plan; definitions vary by provider and are not standardized.
Compounded individualized dosecompoundedA patient-specific dose prepared by a compounding pharmacy under a prescription; not an FDA-approved product.
Oral, sublingual, buccal, ODT, or troche productcompoundedNon-injectable formulations. Two approved oral semaglutide products exist (Rybelsus and the Wegovy pill); compounded oral/sublingual/ODT products are separate and unproven.
Standard compounded injectioncompoundedA compounded injectable at a conventional (non-reduced) dose; not FDA approved.
FDA-approved branded productlabelA manufactured, FDA-approved GLP-1 (e.g., Wegovy, Ozempic, Zepbound, Mounjaro, Rybelsus) with reviewed manufacturing and labeling.

What the evidence shows

  • Labeled doses of semaglutide and tirzepatide produce clinically meaningful weight loss in randomized trials (14.9% in STEP 1; 20.9% at 15 mg in SURMOUNT-1).
  • Lower doses in those trials produced less weight loss, and specific reduced maintenance doses have some trial support.
  • Weight tends to return after stopping (STEP 4, SURMOUNT-4), which is why maintenance strategy matters.

What the evidence does not show

  • That a deliberately low "microdose" produces meaningful weight loss.
  • That injectable-trial results transfer to compounded oral, sublingual or ODT products.
  • That any single microdose schedule is safe or effective across people and concentrations.

Explore

Frequently asked questions

What is GLP-1 microdosing?

GLP-1 microdosing is a marketing term rather than a clinical protocol: it means taking semaglutide or tirzepatide below the doses on the FDA label, usually as a compounded injection, and no regulator or trial has defined which dose counts as a microdose. Programs set their own ranges. As of November 8, 2026, Noom's semaglutide chart tops out at 0.6 mg a week, Lemonaid caps doses at 25% of the standard maintenance dose, and NexLife prints no dose on its microdose pages. Labeled starting doses exist for titration, not as long-term doses. Compounded versions are not FDA-approved.

Does GLP-1 microdosing work for weight loss?

No randomized trial has tested a deliberate GLP-1 microdose for weight loss, so whether it works is unknown; the proven results come from full labeled doses, such as 14.9% average loss on semaglutide 2.4 mg in STEP 1 and 20.9% on tirzepatide 15 mg in SURMOUNT-1. In SURMOUNT-1 the lower 5 mg dose produced less loss (15.0%), which points to a dose-response. Programs advertise fewer side effects at microdoses, but that claim is untested too. If you try one, agree on a goal and a check-in date with your clinician. Compounded microdoses are not FDA-approved.

What is the best GLP-1 microdose program?

Our #1 GLP-1 microdose program is NexLife, which scores 94/100 on our v4.1 rubric and, as of November 8, 2026, prints microdose tirzepatide at $129 a month month to month or $115 on a 12-month plan, and microdose semaglutide at $109 or $95, with provider review included and no membership. Other programs print lower figures under different terms, such as Good Girl Rx's prepaid plans and PlexusDx's existing-patient page. The rubric weighs price transparency, annual cost, clinical oversight and pharmacy disclosure, not price alone. Compounded microdoses are not FDA-approved.

Is a microdose cheaper than a standard dose?

Not at NexLife, where both cost $129 a month for tirzepatide and $109 for semaglutide month to month as of November 8, 2026. Across the programs we track, the median microdose plan costs about what a standard compounded plan does. See microdose vs standard dose.

Why won’t this site give me a microdose chart?

Because a universal chart would be unsafe and unsupported: definitions vary, compounded concentrations differ, and the right dose is an individual clinical decision. We explain the concepts and evidence instead of prescribing.

Not medical advice. This page is consumer education and does not recommend a dose. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.